Avantor opens logistics hub
Avantor has opened a logistics hub in Westminster, MA, to strengthen the company's global biopharma supply chain. The new facility serves as a center for raw material storage, quality control, and distribution to support the growth of Avantor's single-use solutions. Read More
Alethiomics launches to advance multiomics target discovery pipeline
Alethiomics, a drug discovery company focused on developing targeted therapies to treat myeloproliferative neoplasms, launched with 6 million euros ($6.8 million) in seed financing from Oxford Science Enterprises. The company is a spinoff from the University of Oxford. Read More
Akoya Biosciences, PathAI collaborate on novel predictive biomarkers
Akoya Biosciences is collaborating with PathAI to advance the discovery and validation of novel predictive biomarkers for immunotherapies. The collaboration will explore spatial biology and deep data mining using Phenoptic, Akoya's high-throughput spatial phenotyping platform, and PathAI's artificial intelligence (AI) tools and algorithms to identify the patients who are most likely to respond to drug therapy in clinical trials. Read More
Rebus Bio acquires EEL Transcriptomics
Rebus Bio, an Illumina Ventures-backed company, announced that it has acquired the intellectual property and related assay assets of EEL Transcriptomics, a privately held company that develops high-plex spatial transcriptomics with single-cell resolution. Read More
PharmaCyte completes gene integration assay, IND progresses for LAPC
PharmaCyte Biotech has released the results of an additional, more detailed analysis of the integration site of the cytochrome P450 2B1 gene from the augmented HEK293 cell line clone that PharmaCyte uses in its CypCap product. This assay is required by the U.S. Food and Drug Administration (FDA) to lift the clinical hold on PharmaCyte's investigational new drug (IND) application for the treatment of inoperable locally advanced pancreatic cancer (LAPC). Read More
PacBio, UCLA announce research collaboration
Pacific BioSciences (PacBio), the Institute for Precision Health at the University of California, Los Angeles (UCLA), and UCLA's David Geffen School of Medicine have formed a research collaboration to further identify the causes of rare diseases. The collaboration aims to identify variants not easily detectable by short-read sequencing. Read More
Recursion, Roche, Genentech to use machine learning, HCS to drive discovery
Recursion is set to collaborate with Roche and Genentech in the fields of neuroscience and oncology to advance new medicines for patients using large-scale machine-learning and high-content screening (HCS) methods to map complex biology. Read More
Yokogawa develops single cellome system for subcellular sampling
Yokogawa Electric unveiled the single cellome system SS2000, a single-cell analysis solution that automatically collects samples of specific cells and intracellular components. The SS2000 will be released in Japan, the U.S., and China in February 2022, and later in Europe. Read More
Parallel Fluidics secures $1.8M in funding round
Digital microfluidic devices manufacturer Parallel Fluidics has garnered $1.8 million in a new round of financing from a syndicate of investors, founders, and technologists. Read More
Earlham Institute deploys new HiFi platform
The Earlham Institute in Norwich, U.K., has implemented a twin set of Pacific Biosciences' Sequel IIe platform to increase its support for the Earth BioGenome projects. Read More
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter